Optimizing VCTE and ELF Thresholds for Treatment‐Eligible F2–F3 Fibrosis in Japanese Patients With MASLD

Yuya Seko, Taeang Arai, Hirokazu Takahashi, Hidenori Toyoda, Hideki Hayashi, Kanji Yamaguchi, Michihiro Iwaki, Masato Yoneda, Toshihide Shima, Hideki Fujii, Asahiro Morishita, Kazuhito Kawata, Kengo Tomita, Miwa Kawanaka, Yuichi Yoshida, Tadashi Ikegami, Kazuo Notsumata, Satoshi Oeda, Masanori Atsukawa, Yoshihiro Kamada, Yoshio Sumida, Eiji Miyoshi, Shinichi Aishima, Takeshi Okanoue, Tomohisa Takagi, Atsushi Nakajima

Open source

DOI: 10.1111/hepr.70155
Published: 2026-03-12
Container: Hepatology Research
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/hepr.70155,
  title = {Optimizing VCTE and ELF Thresholds for Treatment‐Eligible F2–F3 Fibrosis in Japanese Patients With MASLD},
  author = {Yuya Seko and Taeang Arai and Hirokazu Takahashi and Hidenori Toyoda and Hideki Hayashi and Kanji Yamaguchi and Michihiro Iwaki and Masato Yoneda and Toshihide Shima and Hideki Fujii and Asahiro Morishita and Kazuhito Kawata and Kengo Tomita and Miwa Kawanaka and Yuichi Yoshida and Tadashi Ikegami and Kazuo Notsumata and Satoshi Oeda and Masanori Atsukawa and Yoshihiro Kamada and Yoshio Sumida and Eiji Miyoshi and Shinichi Aishima and Takeshi Okanoue and Tomohisa Takagi and Atsushi Nakajima},
  year = {2026},
  journal = {Hepatology Research},
  doi = {10.1111/hepr.70155},
  url = {https://doi.org/10.1111/hepr.70155}
}

RIS

TY  - JOUR
TI  - Optimizing VCTE and ELF Thresholds for Treatment‐Eligible F2–F3 Fibrosis in Japanese Patients With MASLD
AU  - Yuya Seko
AU  - Taeang Arai
AU  - Hirokazu Takahashi
AU  - Hidenori Toyoda
AU  - Hideki Hayashi
AU  - Kanji Yamaguchi
AU  - Michihiro Iwaki
AU  - Masato Yoneda
AU  - Toshihide Shima
AU  - Hideki Fujii
AU  - Asahiro Morishita
AU  - Kazuhito Kawata
AU  - Kengo Tomita
AU  - Miwa Kawanaka
AU  - Yuichi Yoshida
AU  - Tadashi Ikegami
AU  - Kazuo Notsumata
AU  - Satoshi Oeda
AU  - Masanori Atsukawa
AU  - Yoshihiro Kamada
AU  - Yoshio Sumida
AU  - Eiji Miyoshi
AU  - Shinichi Aishima
AU  - Takeshi Okanoue
AU  - Tomohisa Takagi
AU  - Atsushi Nakajima
PY  - 2026
JO  - Hepatology Research
DO  - 10.1111/hepr.70155
UR  - https://doi.org/10.1111/hepr.70155
ER  -

APA

Seko, Y., Arai, T., Takahashi, H., Toyoda, H., Hayashi, H., Yamaguchi, K., Iwaki, M., Yoneda, M., Shima, T., Fujii, H., Morishita, A., Kawata, K., Tomita, K., Kawanaka, M., Yoshida, Y., Ikegami, T., Notsumata, K., Oeda, S., Atsukawa, M., Kamada, Y., Sumida, Y., Miyoshi, E., Aishima, S., Okanoue, T., Takagi, T., & Nakajima, A. (2026). Optimizing VCTE and ELF Thresholds for Treatment‐Eligible F2–F3 Fibrosis in Japanese Patients With MASLD. Hepatology Research. https://doi.org/10.1111/hepr.70155

Source records

crossref · retrieved 2026-09-27T09:24:52.222Z